PDS BIOTECHNOLOGY CORP (PDSB) Fundamental Analysis & Valuation

NASDAQ:PDSB • US70465T1079

Current stock price

0.9807 USD
+0.01 (+0.79%)
At close:
0.9807 USD
0 (0%)
After Hours:

This PDSB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PDSB Profitability Analysis

1.1 Basic Checks

  • PDSB had negative earnings in the past year.
  • PDSB had a negative operating cash flow in the past year.
  • PDSB had negative earnings in each of the past 5 years.
  • PDSB had a negative operating cash flow in each of the past 5 years.
PDSB Yearly Net Income VS EBIT VS OCF VS FCFPDSB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -113.12%, PDSB is doing worse than 79.61% of the companies in the same industry.
  • PDSB has a worse Return On Equity (-372.85%) than 76.31% of its industry peers.
Industry RankSector Rank
ROA -113.12%
ROE -372.85%
ROIC N/A
ROA(3y)-89.45%
ROA(5y)-69.32%
ROE(3y)-245.03%
ROE(5y)-170.94%
ROIC(3y)N/A
ROIC(5y)N/A
PDSB Yearly ROA, ROE, ROICPDSB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • PDSB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PDSB Yearly Profit, Operating, Gross MarginsPDSB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PDSB Health Analysis

2.1 Basic Checks

  • PDSB has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PDSB has more shares outstanding
  • Compared to 1 year ago, PDSB has a worse debt to assets ratio.
PDSB Yearly Shares OutstandingPDSB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
PDSB Yearly Total Debt VS Total AssetsPDSB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • PDSB has an Altman-Z score of -11.09. This is a bad value and indicates that PDSB is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -11.09, PDSB is not doing good in the industry: 74.56% of the companies in the same industry are doing better.
  • PDSB has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • PDSB's Debt to Equity ratio of 1.27 is on the low side compared to the rest of the industry. PDSB is outperformed by 78.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z -11.09
ROIC/WACCN/A
WACCN/A
PDSB Yearly LT Debt VS Equity VS FCFPDSB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • PDSB has a Current Ratio of 2.98. This indicates that PDSB is financially healthy and has no problem in meeting its short term obligations.
  • PDSB has a Current ratio of 2.98. This is in the lower half of the industry: PDSB underperforms 63.30% of its industry peers.
  • PDSB has a Quick Ratio of 2.98. This indicates that PDSB is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.98, PDSB is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.98
PDSB Yearly Current Assets VS Current LiabilitesPDSB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PDSB Growth Analysis

3.1 Past

  • PDSB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.54%, which is quite impressive.
EPS 1Y (TTM)26.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.2%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 31.83% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y8.33%
EPS Next 2Y5.58%
EPS Next 3Y3.13%
EPS Next 5Y31.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDSB Yearly Revenue VS EstimatesPDSB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 200M 400M 600M 800M
PDSB Yearly EPS VS EstimatesPDSB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

0

4. PDSB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PDSB. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PDSB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PDSB Price Earnings VS Forward Price EarningsPDSB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PDSB Per share dataPDSB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.58%
EPS Next 3Y3.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PDSB Dividend Analysis

5.1 Amount

  • PDSB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PDSB Fundamentals: All Metrics, Ratios and Statistics

PDS BIOTECHNOLOGY CORP

NASDAQ:PDSB (5/1/2026, 5:44:04 PM)

After market: 0.9807 0 (0%)

0.9807

+0.01 (+0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)03-30
Earnings (Next)05-20
Inst Owners14.24%
Inst Owner Change0.02%
Ins Owners1.73%
Ins Owner Change0%
Market Cap54.74M
Revenue(TTM)N/A
Net Income(TTM)-34.50M
Analysts82.22
Price Target7.65 (680.06%)
Short Float %3.16%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.52%
Min EPS beat(2)12.68%
Max EPS beat(2)24.36%
EPS beat(4)4
Avg EPS beat(4)16.34%
Min EPS beat(4)11.76%
Max EPS beat(4)24.36%
EPS beat(8)7
Avg EPS beat(8)17.73%
EPS beat(12)9
Avg EPS beat(12)14.96%
EPS beat(16)11
Avg EPS beat(16)3.16%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.92
P/tB 5.92
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -113.12%
ROE -372.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-89.45%
ROA(5y)-69.32%
ROE(3y)-245.03%
ROE(5y)-170.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 2.98
Altman-Z -11.09
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.2%
EPS Next Y8.33%
EPS Next 2Y5.58%
EPS Next 3Y3.13%
EPS Next 5Y31.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-20.52%
EBIT Next 3Y-14.25%
EBIT Next 5YN/A
FCF growth 1Y20.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.78%
OCF growth 3YN/A
OCF growth 5YN/A

PDS BIOTECHNOLOGY CORP / PDSB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PDS BIOTECHNOLOGY CORP?

ChartMill assigns a fundamental rating of 1 / 10 to PDSB.


Can you provide the valuation status for PDS BIOTECHNOLOGY CORP?

ChartMill assigns a valuation rating of 0 / 10 to PDS BIOTECHNOLOGY CORP (PDSB). This can be considered as Overvalued.


Can you provide the profitability details for PDS BIOTECHNOLOGY CORP?

PDS BIOTECHNOLOGY CORP (PDSB) has a profitability rating of 0 / 10.


Can you provide the financial health for PDSB stock?

The financial health rating of PDS BIOTECHNOLOGY CORP (PDSB) is 2 / 10.


What is the earnings growth outlook for PDS BIOTECHNOLOGY CORP?

The Earnings per Share (EPS) of PDS BIOTECHNOLOGY CORP (PDSB) is expected to grow by 8.33% in the next year.